| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/24/2001 | US6221655 Spin filter assembly for isolation and analysis |
| 04/24/2001 | US6221645 Binds protease which cleaves beta-amyloid precursor protein |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221625 Allowing a test sample to react with an enzyme-labeled reagent, allowing a substrate to react with the enzyme to form a signal, and immobilising the enzyme-labeled reagent, with the prevention of a further signal formation |
| 04/24/2001 | US6221624 Especially suitable for enzyme assays such as enzyme-linked-immunosorbent-assays; storage stability |
| 04/24/2001 | US6221623 Screening for tumorous adjustment in morphology of urogenital tissues; measuring presence of tumor marker protein in urogenital tissues, the presence of the markers is indicative of tumorous classification |
| 04/24/2001 | US6221622 Diagnosing mammary gland tumors; recovering fluid from mammary glands and evaluating the morphology of cells in the recovered fluid |
| 04/24/2001 | US6221621 Methods of screening for colorectal cancers in which a complement Factor I or related protein is associated |
| 04/24/2001 | US6221620 Hybridoma that produces immunoglobulin preferential to enzymatic proteins; for diagnosing colon cancer |
| 04/24/2001 | US6221619 Detecting parasitic infections; incubate test sample with preferential peptides and detecting antibodies, the presence of antibodies indicates parasitic infection |
| 04/24/2001 | US6221618 Detection of modulators which suppresses cardiovascular disorders; incubate heart muscle cells with inducer of cardiovascular disorders, measure development of hypertrophy |
| 04/24/2001 | US6221617 Bioassay for growth hormone releasing hormone |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221615 Detection of modulators cell killing; mixing modulators of heterodimerization and detecting reduction in heterodimer forming activity |
| 04/24/2001 | US6221614 Contacting with a solid substrate comprising a prion complexing agent such as sodium phosphotungstate to bind prions in the sample, separating sample from substrate |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | US6221612 Photon reducing agents for use in fluorescence assays |
| 04/24/2001 | US6221611 Detecting infections by monitoring the amount of adenosine binding protein in urine sample |
| 04/24/2001 | US6221608 Methods for identifying erythropoietin receptor binding protein |
| 04/24/2001 | US6221605 DNA diagnostics based on mass spectrometry |
| 04/24/2001 | US6221602 Functionalized nanocrystals and their use in labeling for strand synthesis or sequence determination |
| 04/24/2001 | US6221601 DNA diagnostics based on mass spectrometry |
| 04/24/2001 | US6221597 Detecting fungicides; incubate test compound with protein and detect binding of test compound to protein |
| 04/24/2001 | US6221593 Diagnosing tumors in cells which express tumor rejection antigen; incubate sample with oligonucleotides, detect hybridization, hybridization is indicative of tumors |
| 04/24/2001 | US6221591 Determination of a genetic risk factor for infection and other diseases, and detection of activated phagocytes |
| 04/24/2001 | US6221590 Method for the quantitative determination of telomerase activity |
| 04/24/2001 | US6221586 Single stranded nucleic acid hybridized to a second single stranded nucleic acid forming a hybridization product for the sensitive and accurate detection of point mutations in genome |
| 04/24/2001 | US6221579 Patterned binding of functionalized microspheres for optical diffraction-based biosensors |
| 04/24/2001 | US6221578 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221576 Process for preparing macrophages, kits, and compositions for the use of this process |
| 04/24/2001 | US6221363 Vaccine for the prevention of lyme disease |
| 04/24/2001 | US6221355 Anti-pathogen system and methods of use thereof |
| 04/24/2001 | US6221353 The use of these proteins in vaccines or for the detection of tuberculosis. |
| 04/24/2001 | US6221352 Method of preventing the proliferation of Vβ14 or Vβ17-Expressing T cells |
| 04/24/2001 | US6221335 Method of using deuterated calcium channel blockers |
| 04/24/2001 | US6221319 Plasma discharge reactors for the preparation of bioactive compounds |
| 04/24/2001 | US6221316 Use of blends of water-resistant and biodegradable polymers made from renewable feedstocks with increased binding affinity for the production of carriers for analytic systems |
| 04/24/2001 | US6221315 Centrifuge, blood, |
| 04/24/2001 | US6221026 Breath test for the detection of various diseases |
| 04/24/2001 | US6220748 Method and apparatus for testing material utilizing differential temperature measurements |
| 04/24/2001 | US6220102 Die-shear test fixture apparatus |
| 04/24/2001 | US6220097 Device for detecting delaminations and methods of use thereof |
| 04/24/2001 | US6220083 Elongational rheometer and on-line process controller |
| 04/24/2001 | US6220076 Differential gas analyzer |
| 04/24/2001 | CA2222223C Method and apparatus for hair color characterization and treatment |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/24/2001 | CA2134636C Toxicity testing assay |
| 04/24/2001 | CA2092713C Spectral data measurement and correction |
| 04/22/2001 | WO2002102250A1 $g(in vivo) imaging |
| 04/22/2001 | CA2422767A1 In vivo imaging |
| 04/21/2001 | CA2321266A1 Anti-dnase-gamma antibody, and production and use thereof |
| 04/21/2001 | CA2313879A1 Method of controlling blood sugar levels using coccoloba uvifera |
| 04/20/2001 | CA2323954A1 Test strip and method for detection of high levels of chloride for swimming pools and spas |
| 04/19/2001 | WO2001027857A2 Methods for generating databases and databases for identifying polymorphic genetic markers |
| 04/19/2001 | WO2001027642A1 Method and system for determining oil quality |
| 04/19/2001 | WO2001027636A1 Method for protecting cooling water systems |
| 04/19/2001 | WO2001027635A1 Multiwell scanner and scanning method |
| 04/19/2001 | WO2001027634A2 Method for determining of autoantibodies against the tsh receptor |
| 04/19/2001 | WO2001027633A1 Gestational agents which modulate cell proliferation |
| 04/19/2001 | WO2001027631A1 Assays for mastitis detecting haptoglobin in milk |
| 04/19/2001 | WO2001027630A2 Methods to identify compounds that modulate neuronal activity |
| 04/19/2001 | WO2001027629A1 Diagnosis of pathologies of mononucleated blood cells |
| 04/19/2001 | WO2001027628A1 Antibiotic-metal complexes in the detection of gram-negative bacteria and other biological analytes |
| 04/19/2001 | WO2001027627A2 Assay device |
| 04/19/2001 | WO2001027626A2 Means and system for carrying out immunoassays |
| 04/19/2001 | WO2001027625A1 Conjugated polymer tag complexes |
| 04/19/2001 | WO2001027624A2 Compositions and methods for detecting protein modification and enzymatic activity |
| 04/19/2001 | WO2001027623A2 Isoagglutinin-depleted blood compositions and methods of making same |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027621A2 Competitive inhibition elisa for antibody detection |
| 04/19/2001 | WO2001027620A1 Method of the diagnosis of renal disorder, hemolytic-uremic syndrome and intestinal hemorrhagic escherichia coli infection |
| 04/19/2001 | WO2001027619A1 Method for detecting exogenous endocrine disrupting chemical and detection apparatus |
| 04/19/2001 | WO2001027618A2 A method for monitoring breast cancer chemotherapy |
| 04/19/2001 | WO2001027617A1 An in vitro phagocytosis method to predict the in vivo potential of integrin antagonists/agonists to induce thrombocytopenia |
| 04/19/2001 | WO2001027616A1 Method for assessing fowl sperm quality |
| 04/19/2001 | WO2001027615A1 Differential gas measurement, in particular for breathing-gas analysis |
| 04/19/2001 | WO2001027614A1 Method and device for taking measurements of cells which are contained in a liquid environment |
| 04/19/2001 | WO2001027613A2 Improved method for the detection of acid resistant microorganisms in a stool |
| 04/19/2001 | WO2001027612A2 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
| 04/19/2001 | WO2001027611A2 Multiplex cytokine analysis |
| 04/19/2001 | WO2001027609A2 Traction-force measuring apparatus with two friction rollers in adjustable planes |
| 04/19/2001 | WO2001027604A1 Method and device for determining gas concentration in a gas mixture |
| 04/19/2001 | WO2001027603A1 Method and system for determining oil quality |
| 04/19/2001 | WO2001027591A2 Method and device for characterizing a culture liquid |
| 04/19/2001 | WO2001027586A1 Preparation method for biological tissue sample and instrument and device therefor |
| 04/19/2001 | WO2001027333A1 Sodd gene expression in cancer |
| 04/19/2001 | WO2001027324A2 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | WO2001027323A1 Method of screening for susceptibility to drug-induced cardiac arrhythmia |
| 04/19/2001 | WO2001027320A1 SUSPENSION SYSTEM FOR SEQUENCING GENETIC SUBSTANCE, METHOD OF SEQUENCING GENETIC SUBSTANCE BY USING THE SUSPENSION SYSTEM, AND METHOD OF HIGH-SPEED SNPs SCORING BY USING THE SUSPENSION SYSTEM |
| 04/19/2001 | WO2001027319A2 Leptin assay based on detecting ang-2 expression |
| 04/19/2001 | WO2001027317A2 Method for distinguishing 5-position methylation changes |
| 04/19/2001 | WO2001027316A1 Luminescence test system |
| 04/19/2001 | WO2001027315A2 For substances acting on msk1 or msk2 |
| 04/19/2001 | WO2001027314A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | WO2001027292A2 Methods and compositions for targeting a cell |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027263A1 Modulate aptamer and method for detecting target protein by using the same |